Cargando…

The role of hepatic microenvironment in hepatic fibrosis development

AIM: Fibrosis is a common pathological feature of most types of chronic liver injuries. There is no specific treatment for liver fibrosis at present. The liver microenvironment, which fosters the survival and activity of liver cells, plays an important role in maintaining the normal structure and ph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Ying, Zhao, Tong, Zhang, Zhengyi, Zhang, Dekui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Gastroenterology & Hepatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677987/ https://www.ncbi.nlm.nih.gov/pubmed/36399108 http://dx.doi.org/10.1080/07853890.2022.2132418

Ejemplares similares

Clinicobiochemical prediction of biopsy-proven cases of severe hepatic fibrosis in patients with chronic hepatitis C infection
por: Jin, Young-Joo, et al.
Publicado: (2014)

Close association of PFASs exposure with hepatic fibrosis than steatosis: evidences from NHANES 2017–2018
por: Cheng, Wenli, et al.
Publicado: (2023)

Hepatic fibrosis and factors associated with liver stiffness in HIV mono-infected individuals
por: Sulyok, Mihály, et al.
Publicado: (2017)

Estimation of fibrosis progression rates for chronic hepatitis C: a systematic review and meta-analysis update
por: Erman, Aysegul, et al.
Publicado: (2019)

Impact of biological agents and tofacitinib for moderate-to-severe ulcerative colitis on health-related quality of life: a protocol for a network meta-analysis
por: Ma, Xueni, et al.
Publicado: (2021)

Fluorofenidone alleviates liver fibrosis by inhibiting hepatic stellate cell autophagy via the TGF-β1/Smad pathway: implications for liver cancer
por: Peng, Xiongqun, et al.
Publicado: (2023)

Nicotinamide riboside exerts protective effect against aging-induced NAFLD-like hepatic dysfunction in mice
por: Han, Xue, et al.
Publicado: (2019)

Hepatic autotaxin overexpression in infants with biliary atresia
por: Udomsinprasert, Wanvisa, et al.
Publicado: (2018)

Preoperative serum hepatitis B virus DNA was a risk factor for hepatocellular carcinoma recurrence after liver transplantation
por: Zhang, Dali, et al.
Publicado: (2022)

Eliminating hepatitis C in a rural Appalachian county: protocol for the Kentucky Viral Hepatitis Treatment Study (KeY Treat), a phase IV, single-arm, open-label trial of sofosbuvir/velpatasvir for the treatment of hepatitis C
por: Havens, Jennifer R, et al.
Publicado: (2021)

Rituximab increases the risk of hepatitis B virus reactivation in non-Hodgkin lymphoma patients who are hepatitis B surface antigen-positive or have resolved hepatitis B virus infection in a real-world setting: a retrospective study
por: Tsai, Yu-Fen, et al.
Publicado: (2019)

The association between serum folate and ultrasound - defined hepatic steatosis
por: Chen, Xingxing, et al.
Publicado: (2023)

Changing incidence of reported viral hepatitis in China from 2004 to 2016: an observational study
por: Zhang, Mingyuan, et al.
Publicado: (2019)

Chronic Hepatitis B stigma in Ghana: a qualitative study with patients and providers
por: Adjei, Charles Ampong, et al.
Publicado: (2019)

Neuroimmunomodulation of adrenoblockers during liver cirrhosis: modulation of hepatic stellate cell activity
por: Medina Pizaño, Mariana Yazmin, et al.
Publicado: (2023)

Association between medication adherence and disease outcomes in patients with hepatitis B-related cirrhosis: a population-based case–control study
por: Fu, Kuo-Yu, et al.
Publicado: (2022)

Treatment effectiveness and side effects of patients with hepatitis C in the prisons of Southern Taiwan: a real-life retrospective analysis
por: Tsai, Yu-Chi, et al.
Publicado: (2023)

Hepatitis C virus infection and hospital-related outcomes: a systematic review protocol
por: Ti, Lianping, et al.
Publicado: (2018)

Establishment and assessment of the hepatic venous pressure gradient using biofluid mechanics (HVPG(BFM)): protocol for a prospective, randomised, non-controlled, multicentre study
por: Lin, Jia-Yun, et al.
Publicado: (2019)

Significant amelioration of hepatitis C virus infection in a hyperendemic area: longitudinal evidence from the COMPACT Study in Taiwan
por: Tsai, Pei-Chien, et al.
Publicado: (2021)

Antiviral therapy effectively improves liver hemodynamics as evidenced by serum biomarker and contrast-enhanced ultrasound examinations in patients with hepatitis B cirrhosis
por: Xu, Xiaoyong, et al.
Publicado: (2018)

Beyond the diagnosis: a qualitative exploration of the experiences of persons with hepatitis B in the Accra Metropolis, Ghana
por: Adjei, Charles Ampong, et al.
Publicado: (2017)

Retrospective observational study of temporal trends and outcomes of hepatitis B screening in patients receiving rituximab
por: Haider, Mahnur, et al.
Publicado: (2020)

Risk factors for post-endoscopic retrograde cholangiopancreatography cholangitis in patients with hepatic alveolar echinococcosis—an observational study
por: Du, Fei, et al.
Publicado: (2022)

Antiviral therapy for prevention of hepatocellular carcinoma and mortality in chronic hepatitis B: systematic review and meta-analysis
por: Thiele, Maja, et al.
Publicado: (2013)

Mixed-methods evaluation of point-of-care hepatitis C virus RNA testing in a Scottish prison
por: Byrne, Christopher J, et al.
Publicado: (2023)

Safety, pharmacokinetics and pharmacodynamics of a novel γ-aminobutyric acid (GABA) receptor potentiator, HSK3486, in Chinese patients with hepatic impairment
por: Hu, Yue, et al.
Publicado: (2022)

Association between visceral obesity and hepatitis C infection stratified by gender: a cross-sectional study in Taiwan
por: Tsao, Yu-Chung, et al.
Publicado: (2017)

Antiviral therapy for prevention of hepatocellular carcinoma in chronic hepatitis C: systematic review and meta-analysis of randomised controlled trials
por: Kimer, Nina, et al.
Publicado: (2012)

Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study
por: Chen, Qiushi, et al.
Publicado: (2019)

Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort study
por: Huang, Chung-Feng, et al.
Publicado: (2019)

Diagnostic performance and prognostic value of elastography in patients with biliary atresia and after hepatic portoenterostomy: protocol for a systematic review and meta-analysis
por: Yan, Hualin, et al.
Publicado: (2021)

Hepatic venous pressure gradient-guided laparoscopic splenectomy and pericardial devascularisation versus endoscopic therapy for secondary prophylaxis for variceal rebleeding in portal hypertension (CHESS1803): study protocol of a multicenter randomised controlled trial in China
por: Shao, Ruoyang, et al.
Publicado: (2020)

Utilization of hepatitis B surface antigen-positive donors in liver transplantation for recipients with hepatocellular carcinoma: a retrospective and propensity score matching analysis
por: Chen, Zhitao, et al.
Publicado: (2023)

A comparative study on roles of natural killer T cells in two diet-induced non-alcoholic steatohepatitis-related fibrosis in mice
por: Zheng, Shumei, et al.
Publicado: (2022)

The impact of IL-6 and IL-28B gene polymorphisms on treatment outcome of chronic hepatitis C infection among intravenous drug users in Croatia
por: Bogdanović, Zoran, et al.
Publicado: (2016)

LINK-B: study protocol of a retrospective and prospective project for identification and linkage to care of people living with hepatitis B in a large health area of Barcelona
por: Barreira Díaz, Ana, et al.
Publicado: (2022)

Clinical effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: a study protocol for a pragmatic cluster randomised trial
por: Radley, Andrew, et al.
Publicado: (2018)

Efficacy and safety of combination treatment of double plasma molecular adsorption system and low volume plasma exchange for patients with hepatitis B virus related acute-on-chronic liver failure: a multicentre randomised controlled clinical trial
por: Xu, Wenxiong, et al.
Publicado: (2021)

Village-to-village screening for hepatitis B and C using quantitative HBsAg and anti-HCV testing with reflex HCV core antigen tests in the remote communities of a resource-rich setting: a population-based prospective cohort study
por: Chang, Te-Sheng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c5hnsan2akn8uodfciir9gcc35